Zydus Lifesciences gain on US FDA approval for diabetic drug
Zydus Lifesciences on October 20 announced that the USFDA approved its New Drug Application (NDA) for ZITUVIOTM (Sitagliptin) tablets, 25 mg, 50 mg, and 100 mg, company said in its statement.